Commitments and Contingencies - Additional Information (Detail) - Plexxikon License Agreement [Member] - USD ($) |
1 Months Ended | 6 Months Ended | |
---|---|---|---|
Jul. 30, 2020 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|
Commitments And Contingencies Disclosure [Line Items] | |||
Clinical milestone achieved, triggering payment | $ 2,500,000 | ||
Other milestone payments | $ 0 | ||
License agreement expiration terms | The license agreement will expire on a country-by-country and licensed product-by-licensed product basis until the later of the last to expire of the patents covering such licensed products or services or the 10-year anniversary of the date of first commercial sale of the licensed product in such country. The Company may terminate the license agreement within 30 days after written notice in the event of a material breach. The Company may also terminate the agreement upon written notice in the event of the Company’s bankruptcy, liquidation or insolvency. In addition, the Company has the right to terminate this agreement in its entirety at will upon 90 days’ advance written notice to Plexxikon. | ||
Maximum [Member] | |||
Commitments And Contingencies Disclosure [Line Items] | |||
Aggregate payments received upon satisfaction of clinical milestones | $ 7,500,000 | ||
Aggregate payments received | $ 25,000,000.0 |